Literature DB >> 9114201

Oral administration of antibiotics: a rational alternative to the parenteral route.

R R MacGregor1, A L Graziani.   

Abstract

Much early experience with antibiotic therapy involved oral administration of sulfonamides, penicillins, tetracyclines, and chloramphenicol. Newer acid-labile, less-soluble agents created the need for intravenous (i.v.) administration, and i.v. technology (hyporeactive catheter polymers, infusion pumps, etc.) improved to where i.v. administration became normative for the treatment of serious infections. Recently, this preference is being reconsidered in light of agents that are highly effective orally, growing appreciation that i.v. treatment has serious complications, and economic pressures to provide the best care at the lowest cost. This article presents a brief history of administration routes and reviews the rationale for considering oral treatment for serious infections, including consideration of pharmacokinetics and minimum inhibitory concentrations. Published reports supporting the efficacy of orally administered antibiotics either as sole treatment or following an initial parenteral course are reviewed in detail, and examples of programs that educate physicians about the rationale, acceptibility, and benefits of oral administration are given.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9114201     DOI: 10.1093/clinids/24.3.457

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  22 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

2.  Alterations to the Gut Microbiome Impair Bone Strength and Tissue Material Properties.

Authors:  Jason D Guss; Michael W Horsfield; Fernanda F Fontenele; Taylor N Sandoval; Marysol Luna; Fnu Apoorva; Svetlana F Lima; Rodrigo C Bicalho; Ankur Singh; Ruth E Ley; Marjolein Ch van der Meulen; Steven R Goldring; Christopher J Hernandez
Journal:  J Bone Miner Res       Date:  2017-03-27       Impact factor: 6.741

Review 3.  Snake venoms: attractive antimicrobial proteinaceous compounds for therapeutic purposes.

Authors:  Nelson Gomes de Oliveira Junior; Marlon Henrique e Silva Cardoso; Octavio Luiz Franco
Journal:  Cell Mol Life Sci       Date:  2013-05-09       Impact factor: 9.261

4.  Clinical Equivalency of Ciprofloxacin 750 mg Enterally and 400 mg Intravenously for Patients Receiving Enteral Feeding: Systematic Review.

Authors:  Donna Chui; Lily Cheng; Aaron M Tejani
Journal:  Can J Hosp Pharm       Date:  2009-03

5.  The microbial metagenome and bone tissue composition in mice with microbiome-induced reductions in bone strength.

Authors:  Jason D Guss; Erik Taylor; Zach Rouse; Sebastian Roubert; Catherine H Higgins; Corinne J Thomas; Shefford P Baker; Deepak Vashishth; Eve Donnelly; M Kyla Shea; Sarah L Booth; Rodrigo C Bicalho; Christopher J Hernandez
Journal:  Bone       Date:  2019-06-14       Impact factor: 4.398

6.  Impact of switching from intravenous to oral linezolid therapy in Japanese patients: a retrospective cohort study.

Authors:  Akihiro Tanaka; Akiko Yano; Shinichi Watanabe; Mamoru Tanaka; Hiroaki Araki
Journal:  J Pharm Policy Pract       Date:  2016-10-28

7.  Disruption of the Gut Microbiome Increases the Risk of Periprosthetic Joint Infection in Mice.

Authors:  Christopher J Hernandez; Xu Yang; Gang Ji; Yingzhen Niu; Arvinth S Sethuraman; Joseph Koressel; Matthew Shirley; Michael W Fields; Susan Chyou; Thomas M Li; Marysol Luna; Rowan L Callahan; F Patrick Ross; Theresa T Lu; Ilana L Brito; Alberto V Carli; Mathias P G Bostrom
Journal:  Clin Orthop Relat Res       Date:  2019-11       Impact factor: 4.176

Review 8.  Recent Advances in Oral Nano-Antibiotics for Bacterial Infection Therapy.

Authors:  Ze-Liang Wu; Jun Zhao; Rong Xu
Journal:  Int J Nanomedicine       Date:  2020-12-01

Review 9.  The "Choosing Wisely" initiative in infectious diseases.

Authors:  Clara Lehmann; Reinhard Berner; Johannes R Bogner; Oliver A Cornely; Katja de With; Susanne Herold; Winfried V Kern; Sebastian Lemmen; Mathias W Pletz; Bernhard Ruf; Bernd Salzberger; Hans Jürgen Stellbrink; Norbert Suttorp; Andrew J Ullmann; Gerd Fätkenheuer; Norma Jung
Journal:  Infection       Date:  2017-03-13       Impact factor: 3.553

10.  Outcomes of early switching from intravenous to oral antibiotics on medical wards.

Authors:  Dominik Mertz; Michael Koller; Patricia Haller; Markus L Lampert; Herbert Plagge; Balthasar Hug; Gian Koch; Manuel Battegay; Ursula Flückiger; Stefano Bassetti
Journal:  J Antimicrob Chemother       Date:  2009-04-28       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.